+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drug-eluting Balloon Catheters Market: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 220 Pages
  • September 2024
  • Region: Global
  • Allied Market Research
  • ID: 6054035
The drug-eluting balloon catheters market was valued at $0.6 billion in 2023, and is projected to reach $1.5 billion by 2033, growing at a CAGR of 8.7% from 2024 to 2033.

Drug-eluting balloon catheters are specialized medical devices used in interventional cardiology and vascular procedures. These catheters are coated with medication that is released into the target tissue during the balloon inflation process. This technology aims to prevent restenosis (re-narrowing of blood vessels) after procedures such as angioplasty, where a balloon is used to open up blocked arteries.

The growth of the global drug-eluting balloon catheters market is majorly driven by alarming rise in prevalence of cardiovascular diseases such as coronary artery disease and peripheral artery disease. According to a 2023 study of the World Heart Federation, deaths due to cardiovascular disease increased from 12.1 million in 1990 to 20.5 million in 2021. In addition, surge in geriatric population significantly contributes toward the growth of the global market.

This is attributed to the fact that as individuals age, their bodies undergo natural physiological changes such as arterial stiffness, reduced elasticity of blood vessels, and changes in heart structure and function, which can contribute to conditions like hypertension and heart disease. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050. Moreover, shift toward minimally invasive surgical techniques among healthcare providers and patients leads to higher demand for drug-eluting balloons, thereby augmenting the market growth.

Furthermore, increase in investments in healthcare infrastructure and growing spending on advanced medical devices contribute to the market expansion. However, high cost associated with drug-eluting balloon catheters hampers the market growth. In addition, availability of other treatment options, such as drug-eluting stents or traditional surgical procedures, can create competitive pressures and limit the market share for drug-eluting balloon catheters. On the contrary, continuous innovations in catheter design and drug formulation improve the effectiveness and safety profiles of drug-eluting balloon catheters, which are expected to offer lucrative opportunities for the growth of the global market during the forecast period.

The global drug-eluting balloon catheters market size is segmented into product type, indication, end user, and region. By product type, the market is bifurcated into paclitaxel drug-eluting balloon catheters and sirolimus drug-eluting balloon catheters. On the basis of indication, it is classified into coronary intervention and peripheral intervention. Depending on end user, it is fragmented into hospitals and ASCs, catheterization laboratories, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product type, the paclitaxel drug-eluting balloon catheters segment is expected to dominate the market from 2024 to 2033.

On the basis of indication, the peripheral intervention segment is anticipated to exhibit the highest growth during the forecast period.

Depending on end user, hospital segment is likely to grow at a notable pace in the coming years.

Region wise, North America is projected to emerge as the most lucrative market for drug-eluting balloon catheters throughout the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global drug-eluting balloon catheters market include Medtronic, Koninklijke Philips N.V., Becton, Dickinson and Company, Lepu Medical Technology(Beijing)Co.,Ltd., Meril Life Sciences Pvt. Ltd., Biotronik, Zhejiang Barty Medical Technology Co., Ltd., Eurocor Tech GmbH, iVascular, and Concept Medical. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update* (with the purchase of an enterprise license)
  • 5 additional Company Profiles, pre- or post-purchase, as a free update.
  • Free Updated Version (once released) with the purchase of an enterprise user license.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product Type

  • Paclitaxel Drug-Eluting Balloon Catheters
  • Sirolimus Drug-Eluting Balloon Catheters

By Indication

  • Coronary Intervention
  • Peripheral Intervention

By End User

  • Hospitals and ASCs
  • Catheterization Laboratories
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Medtronic
  • Koninklijke Philips N.V.
  • Becton, Dickinson and Company
  • Lepu Medical Technology(Beijing)Co.,Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • Biotronik
  • Zhejiang Barty Medical Technology Co., Ltd.
  • Eurocor Tech GmbH
  • iVascular
  • Concept Medical

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: DRUG-ELUTING BALLOON CATHETERS MARKET, BY PRODUCT TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product Type
4.2. Paclitaxel Drug-Eluting Balloon Catheters
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Sirolimus Drug-Eluting Balloon Catheters
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: DRUG-ELUTING BALLOON CATHETERS MARKET, BY INDICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Indication
5.2. Coronary Intervention
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Peripheral Intervention
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: DRUG-ELUTING BALLOON CATHETERS MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals And ASCs
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Catheterization Laboratories
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: DRUG-ELUTING BALLOON CATHETERS MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product Type
7.2.3. Market Size and Forecast, By Indication
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Drug-eluting Balloon Catheters Market
7.2.6.1. Market Size and Forecast, By Product Type
7.2.6.2. Market Size and Forecast, By Indication
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Drug-eluting Balloon Catheters Market
7.2.7.1. Market Size and Forecast, By Product Type
7.2.7.2. Market Size and Forecast, By Indication
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Drug-eluting Balloon Catheters Market
7.2.8.1. Market Size and Forecast, By Product Type
7.2.8.2. Market Size and Forecast, By Indication
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product Type
7.3.3. Market Size and Forecast, By Indication
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Drug-eluting Balloon Catheters Market
7.3.6.1. Market Size and Forecast, By Product Type
7.3.6.2. Market Size and Forecast, By Indication
7.3.6.3. Market Size and Forecast, By End User
7.3.7. France Drug-eluting Balloon Catheters Market
7.3.7.1. Market Size and Forecast, By Product Type
7.3.7.2. Market Size and Forecast, By Indication
7.3.7.3. Market Size and Forecast, By End User
7.3.8. UK Drug-eluting Balloon Catheters Market
7.3.8.1. Market Size and Forecast, By Product Type
7.3.8.2. Market Size and Forecast, By Indication
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Italy Drug-eluting Balloon Catheters Market
7.3.9.1. Market Size and Forecast, By Product Type
7.3.9.2. Market Size and Forecast, By Indication
7.3.9.3. Market Size and Forecast, By End User
7.3.10. Spain Drug-eluting Balloon Catheters Market
7.3.10.1. Market Size and Forecast, By Product Type
7.3.10.2. Market Size and Forecast, By Indication
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest Of Europe Drug-eluting Balloon Catheters Market
7.3.11.1. Market Size and Forecast, By Product Type
7.3.11.2. Market Size and Forecast, By Indication
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product Type
7.4.3. Market Size and Forecast, By Indication
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Drug-eluting Balloon Catheters Market
7.4.6.1. Market Size and Forecast, By Product Type
7.4.6.2. Market Size and Forecast, By Indication
7.4.6.3. Market Size and Forecast, By End User
7.4.7. China Drug-eluting Balloon Catheters Market
7.4.7.1. Market Size and Forecast, By Product Type
7.4.7.2. Market Size and Forecast, By Indication
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Drug-eluting Balloon Catheters Market
7.4.8.1. Market Size and Forecast, By Product Type
7.4.8.2. Market Size and Forecast, By Indication
7.4.8.3. Market Size and Forecast, By End User
7.4.9. Australia Drug-eluting Balloon Catheters Market
7.4.9.1. Market Size and Forecast, By Product Type
7.4.9.2. Market Size and Forecast, By Indication
7.4.9.3. Market Size and Forecast, By End User
7.4.10. South Korea Drug-eluting Balloon Catheters Market
7.4.10.1. Market Size and Forecast, By Product Type
7.4.10.2. Market Size and Forecast, By Indication
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Drug-eluting Balloon Catheters Market
7.4.11.1. Market Size and Forecast, By Product Type
7.4.11.2. Market Size and Forecast, By Indication
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product Type
7.5.3. Market Size and Forecast, By Indication
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Drug-eluting Balloon Catheters Market
7.5.6.1. Market Size and Forecast, By Product Type
7.5.6.2. Market Size and Forecast, By Indication
7.5.6.3. Market Size and Forecast, By End User
7.5.7. Saudi Arabia Drug-eluting Balloon Catheters Market
7.5.7.1. Market Size and Forecast, By Product Type
7.5.7.2. Market Size and Forecast, By Indication
7.5.7.3. Market Size and Forecast, By End User
7.5.8. South Africa Drug-eluting Balloon Catheters Market
7.5.8.1. Market Size and Forecast, By Product Type
7.5.8.2. Market Size and Forecast, By Indication
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Drug-eluting Balloon Catheters Market
7.5.9.1. Market Size and Forecast, By Product Type
7.5.9.2. Market Size and Forecast, By Indication
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Medtronic
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Koninklijke Philips N.V.
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Becton, Dickinson And Company
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Lepu Medical Technology (Beijing) Co., Ltd.
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Meril Life Sciences Pvt. Ltd.
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Biotronik
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Zhejiang Barty Medical Technology Co., Ltd.
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Eurocor Tech GmbH
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. IVascular
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Concept Medical
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
LIST OF TABLES
Table 1. Global Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 2. Drug-Eluting Balloon Catheters Market for Paclitaxel Drug-Eluting Balloon Catheters, by Region, 2024 - 2033 ($Billion)
Table 3. Drug-Eluting Balloon Catheters Market for Sirolimus Drug-Eluting Balloon Catheters, by Region, 2024 - 2033 ($Billion)
Table 4. Global Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 5. Drug-Eluting Balloon Catheters Market for Coronary Intervention, by Region, 2024 - 2033 ($Billion)
Table 6. Drug-Eluting Balloon Catheters Market for Peripheral Intervention, by Region, 2024 - 2033 ($Billion)
Table 7. Global Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 8. Drug-Eluting Balloon Catheters Market for Hospitals and Ascs, by Region, 2024 - 2033 ($Billion)
Table 9. Drug-Eluting Balloon Catheters Market for Catheterization Laboratories, by Region, 2024 - 2033 ($Billion)
Table 10. Drug-Eluting Balloon Catheters Market for Others, by Region, 2024 - 2033 ($Billion)
Table 11. Drug-Eluting Balloon Catheters Market, by Region, 2024 - 2033 ($Billion)
Table 12. North America Drug-Eluting Balloon Catheters Market, by Country, 2024 - 2033 ($Billion)
Table 13. North America Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 14. North America Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 15. North America Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 16. U.S. Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 17. U.S. Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 18. U.S. Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 19. Canada Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 20. Canada Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 21. Canada Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 22. Mexico Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 23. Mexico Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 24. Mexico Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 25. Europe Drug-Eluting Balloon Catheters Market, by Country, 2024 - 2033 ($Billion)
Table 26. Europe Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 27. Europe Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 28. Europe Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 29. Germany Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 30. Germany Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 31. Germany Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 32. France Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 33. France Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 34. France Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 35. UK Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 36. UK Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 37. UK Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 38. Italy Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 39. Italy Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 40. Italy Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 41. Spain Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 42. Spain Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 43. Spain Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 44. Rest of Europe Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 45. Rest of Europe Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 46. Rest of Europe Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 47. Asia-Pacific Drug-Eluting Balloon Catheters Market, by Country, 2024 - 2033 ($Billion)
Table 48. Asia-Pacific Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 49. Asia-Pacific Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 50. Asia-Pacific Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 51. Japan Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 52. Japan Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 53. Japan Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 54. China Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 55. China Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 56. China Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 57. India Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 58. India Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 59. India Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 60. Australia Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 61. Australia Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 62. Australia Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 63. South Korea Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 64. South Korea Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 65. South Korea Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 66. Rest of Asia-Pacific Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 67. Rest of Asia-Pacific Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 68. Rest of Asia-Pacific Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 69. LAMEA Drug-Eluting Balloon Catheters Market, by Country, 2024 - 2033 ($Billion)
Table 70. LAMEA Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 71. LAMEA Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 72. LAMEA Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 73. Brazil Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 74. Brazil Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 75. Brazil Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 76. Saudi Arabia Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 77. Saudi Arabia Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 78. Saudi Arabia Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 79. South Africa Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 80. South Africa Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 81. South Africa Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 82. Rest of LAMEA Drug-Eluting Balloon Catheters Market, by Product Type, 2024 - 2033 ($Billion)
Table 83. Rest of LAMEA Drug-Eluting Balloon Catheters Market, by Indication, 2024 - 2033 ($Billion)
Table 84. Rest of LAMEA Drug-Eluting Balloon Catheters Market, by End-user, 2024 - 2033 ($Billion)
Table 85. Medtronic: Key Executives
Table 86. Medtronic: Company Snapshot
Table 87. Medtronic: Operating Segments
Table 88. Medtronic: Product Portfolio
Table 89. Medtronic: Key Strategic Moves and Developments
Table 90. Koninklijke Philips N.V.: Key Executives
Table 91. Koninklijke Philips N.V.: Company Snapshot
Table 92. Koninklijke Philips N.V.: Operating Segments
Table 93. Koninklijke Philips N.V.: Product Portfolio
Table 94. Koninklijke Philips N.V.: Key Strategic Moves and Developments
Table 95. Becton, Dickinson and Company: Key Executives
Table 96. Becton, Dickinson and Company: Company Snapshot
Table 97. Becton, Dickinson and Company: Operating Segments
Table 98. Becton, Dickinson and Company: Product Portfolio
Table 99. Becton, Dickinson and Company: Key Strategic Moves and Developments
Table 100. Lepu Medical Technology (Beijing) Co. Ltd.: Key Executives
Table 101. Lepu Medical Technology (Beijing) Co. Ltd.: Company Snapshot
Table 102. Lepu Medical Technology (Beijing) Co. Ltd.: Operating Segments
Table 103. Lepu Medical Technology (Beijing) Co. Ltd.: Product Portfolio
Table 104. Lepu Medical Technology (Beijing) Co. Ltd.: Key Strategic Moves and Developments
Table 105. Meril Life Sciences Pvt. Ltd.: Key Executives
Table 106. Meril Life Sciences Pvt. Ltd.: Company Snapshot
Table 107. Meril Life Sciences Pvt. Ltd.: Operating Segments
Table 108. Meril Life Sciences Pvt. Ltd.: Product Portfolio
Table 109. Meril Life Sciences Pvt. Ltd.: Key Strategic Moves and Developments
Table 110. Biotronik: Key Executives
Table 111. Biotronik: Company Snapshot
Table 112. Biotronik: Operating Segments
Table 113. Biotronik: Product Portfolio
Table 114. Biotronik: Key Strategic Moves and Developments
Table 115. Zhejiang Barty Medical Technology Co. Ltd.: Key Executives
Table 116. Zhejiang Barty Medical Technology Co. Ltd.: Company Snapshot
Table 117. Zhejiang Barty Medical Technology Co. Ltd.: Operating Segments
Table 118. Zhejiang Barty Medical Technology Co. Ltd.: Product Portfolio
Table 119. Zhejiang Barty Medical Technology Co. Ltd.: Key Strategic Moves and Developments
Table 120. Eurocor Tech GmbH: Key Executives
Table 121. Eurocor Tech GmbH: Company Snapshot
Table 122. Eurocor Tech GmbH: Operating Segments
Table 123. Eurocor Tech GmbH: Product Portfolio
Table 124. Eurocor Tech GmbH: Key Strategic Moves and Developments
Table 125. Ivascular: Key Executives
Table 126. Ivascular: Company Snapshot
Table 127. Ivascular: Operating Segments
Table 128. Ivascular: Product Portfolio
Table 129. Ivascular: Key Strategic Moves and Developments
Table 130. Concept Medical: Key Executives
Table 131. Concept Medical: Company Snapshot
Table 132. Concept Medical: Operating Segments
Table 133. Concept Medical: Product Portfolio
Table 134. Concept Medical: Key Strategic Moves and Developments
LIST OF FIGURES
Figure 1. Global Drug-Eluting Balloon Catheters Market, 2024 - 2033
Figure 2. Segmentation of Drug-Eluting Balloon Catheters Market, 2024 - 2033
Figure 3. Top Investment Pocket in Drug-Eluting Balloon Catheters Market
Figure 4. Moderate Bargaining Power of Buyers
Figure 5. Moderate Bargaining Power of Suppliers
Figure 6. Moderate Threat of New Entrants
Figure 7. Low Threat of Substitution
Figure 8. High Competitive Rivalry
Figure 9. Opportunities, Restraints and Drivers: Globaldrug-Eluting Balloon Catheters Market
Figure 10. Global Drug-Eluting Balloon Catheters Market Segmentation, by Product Type
Figure 11. Drug-Eluting Balloon Catheters Market for Paclitaxel Drug-Eluting Balloon Catheters, by Country, 2024 - 2033 ($Billion)
Figure 12. Drug-Eluting Balloon Catheters Market for Sirolimus Drug-Eluting Balloon Catheters, by Country, 2024 - 2033 ($Billion)
Figure 13. Global Drug-Eluting Balloon Catheters Market Segmentation, by Indication
Figure 14. Drug-Eluting Balloon Catheters Market for Coronary Intervention, by Country, 2024 - 2033 ($Billion)
Figure 15. Drug-Eluting Balloon Catheters Market for Peripheral Intervention, by Country, 2024 - 2033 ($Billion)
Figure 16. Global Drug-Eluting Balloon Catheters Market Segmentation, by End-user
Figure 17. Drug-Eluting Balloon Catheters Market for Hospitals and Ascs, by Country, 2024 - 2033 ($Billion)
Figure 18. Drug-Eluting Balloon Catheters Market for Catheterization Laboratories, by Country, 2024 - 2033 ($Billion)
Figure 19. Drug-Eluting Balloon Catheters Market for Others, by Country, 2024 - 2033 ($Billion)
Figure 20. Top Winning Strategies, by Year, 2021-2023*
Figure 21. Top Winning Strategies, by Development, 2021-2023*
Figure 22. Top Winning Strategies, by Company, 2021-2023*
Figure 23. Product Mapping of Top 10 Players
Figure 24. Competitive Dashboard
Figure 25. Competitive Heatmap: Drug-Eluting Balloon Catheters Market
Figure 26. Top Player Positioning, 2023
Figure 27. Medtronic: Net Sales, 2021-2023 ($Billion)
Figure 28. Medtronic: Revenue Share, by Segment, 2023 (%)
Figure 29. Medtronic: Revenue Share, by Region, 2023 (%)
Figure 30. Koninklijke Philips N.V.: Net Sales, 2021-2023 ($Billion)
Figure 31. Koninklijke Philips N.V.: Revenue Share, by Segment, 2023 (%)
Figure 32. Koninklijke Philips N.V.: Revenue Share, by Region, 2023 (%)
Figure 33. Becton, Dickinson and Company: Net Sales, 2021-2023 ($Billion)
Figure 34. Becton, Dickinson and Company: Revenue Share, by Segment, 2023 (%)
Figure 35. Becton, Dickinson and Company: Revenue Share, by Region, 2023 (%)
Figure 36. Lepu Medical Technology (Beijing) Co. Ltd.: Net Sales, 2021-2023 ($Billion)
Figure 37. Lepu Medical Technology (Beijing) Co. Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 38. Lepu Medical Technology (Beijing) Co. Ltd.: Revenue Share, by Region, 2023 (%)
Figure 39. Meril Life Sciences Pvt. Ltd.: Net Sales, 2021-2023 ($Billion)
Figure 40. Meril Life Sciences Pvt. Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 41. Meril Life Sciences Pvt. Ltd.: Revenue Share, by Region, 2023 (%)
Figure 42. Biotronik: Net Sales, 2021-2023 ($Billion)
Figure 43. Biotronik: Revenue Share, by Segment, 2023 (%)
Figure 44. Biotronik: Revenue Share, by Region, 2023 (%)
Figure 45. Zhejiang Barty Medical Technology Co. Ltd.: Net Sales, 2021-2023 ($Billion)
Figure 46. Zhejiang Barty Medical Technology Co. Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 47. Zhejiang Barty Medical Technology Co. Ltd.: Revenue Share, by Region, 2023 (%)
Figure 48. Eurocor Tech GmbH: Net Sales, 2021-2023 ($Billion)
Figure 49. Eurocor Tech GmbH: Revenue Share, by Segment, 2023 (%)
Figure 50. Eurocor Tech GmbH: Revenue Share, by Region, 2023 (%)
Figure 51. Ivascular: Net Sales, 2021-2023 ($Billion)
Figure 52. Ivascular: Revenue Share, by Segment, 2023 (%)
Figure 53. Ivascular: Revenue Share, by Region, 2023 (%)
Figure 54. Concept Medical: Net Sales, 2021-2023 ($Billion)
Figure 55. Concept Medical: Revenue Share, by Segment, 2023 (%)
Figure 56. Concept Medical: Revenue Share, by Region, 2023 (%)

Companies Mentioned

  • Medtronic
  • Koninklijke Philips N.V.
  • Becton, Dickinson and Company
  • Lepu Medical Technology(Beijing)Co.,Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • Biotronik
Zhejiang Barty Medical Technology Co., Ltd.
  • Eurocor Tech GmbH
  • iVascular
  • Concept Medical

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information